XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock Shares
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect Adjustment Due to Adoption
Retained Earnings
Retained Earnings
Cumulative Effect Adjustment Due to Adoption
Accumulated Other Comprehensive (Loss)
Total Equity - Greenbrier
Total Equity - Greenbrier
Cumulative Effect Adjustment Due to Adoption
Noncontrolling Interest
Equity Excluding Contingently Redeemable Noncontrolling Interest
Equity Excluding Contingently Redeemable Noncontrolling Interest
Cumulative Effect Adjustment Due to Adoption
Contingently Redeemable Noncontrolling Interest
Beginning balance at Aug. 31, 2020     $ 460.4   $ 885.5 $ (0.5) $ (52.8) $ 1,293.1 $ (0.5) $ 180.0 $ 1,473.1 $ (0.5)  
Beginning balance (in shares) at Aug. 31, 2020   32,700                      
Beginning balance at Aug. 31, 2020                         $ 31.1
Accounting Standards Update [Extensible List]         ASU 2016-13     ASU 2016-13     ASU 2016-13    
Net earnings (loss) $ (20.6)       $ (19.1)     $ (19.1)   (0.4) $ (19.5)   (1.1)
Other comprehensive income (loss), net 6.1           6.1 6.1     6.1    
Noncontrolling interest adjustments                   (1.3) (1.3)    
Joint venture partner distribution declared                   (2.4) (2.4)    
Restricted stock awards (net of cancellations)     15.5         15.5     15.5    
Restricted stock awards (net of cancellations) (in shares)   100                      
Unamortized restricted stock     (17.9)         (17.9)     (17.9)    
Restricted stock amortization     9.0         9.0     9.0    
Cash dividends         (17.7)     (17.7)     (17.7)    
Ending balance at Feb. 28, 2021     467.0   848.2   (46.7) 1,268.5   175.9 1,444.4    
Ending Balance (in shares) at Feb. 28, 2021   32,800                      
Ending Balance at Feb. 28, 2021                         30.0
Beginning balance at Nov. 30, 2020     462.5   866.4   (48.5) 1,280.4   180.5 1,460.9    
Beginning balance (in shares) at Nov. 30, 2020   32,800                      
Beginning balance at Nov. 30, 2020                         30.7
Net earnings (loss) (13.9)       (9.1)   (9.1)   (4.2) (13.3)   (0.7)
Other comprehensive income (loss), net 1.8           1.8 1.8     1.8    
Joint venture partner distribution declared                   (0.4) (0.4)    
Restricted stock awards (net of cancellations)     1.3         1.3     1.3    
Unamortized restricted stock     (1.3)         (1.3)     (1.3)    
Restricted stock amortization     4.5         4.5     4.5    
Cash dividends         (9.1)     (9.1)     (9.1)    
Ending balance at Feb. 28, 2021     467.0   848.2   (46.7) 1,268.5   175.9 1,444.4    
Ending Balance (in shares) at Feb. 28, 2021   32,800                      
Ending Balance at Feb. 28, 2021                         30.0
Beginning balance at Aug. 31, 2021 $ 1,476.4   $ 469.7 $ (58.8) $ 881.7 $ 4.9 (43.7) $ 1,307.7 $ (53.9) 168.7 $ 1,476.4 $ (53.9)  
Beginning balance (in shares) at Aug. 31, 2021 32,397 32,400                      
Beginning balance at Aug. 31, 2021                         29.7
Accounting Standards Update [Extensible List]     ASU 2020-06   ASU 2020-06     ASU 2020-06     ASU 2020-06    
Net earnings (loss) $ 16.8       $ 23.6     $ 23.6   (5.6) $ 18.0   (1.2)
Other comprehensive income (loss), net (9.6)           (9.6) (9.6)     (9.6)    
Noncontrolling interest adjustments                   (0.6) (0.6)    
Joint venture partner distribution declared                   (8.4) (8.4)    
Restricted stock awards (net of cancellations)     $ 11.9         11.9     11.9    
Restricted stock awards (net of cancellations) (in shares)   200                      
Unamortized restricted stock     (15.3)         (15.3)     (15.3)    
Restricted stock amortization     5.9         5.9     5.9    
Cash dividends         (17.7)     (17.7)     (17.7)    
Ending balance at Feb. 28, 2022 $ 1,406.7 $ 32.6 413.4   892.5   (53.3) 1,252.6   154.1 1,406.7   28.5
Ending Balance (in shares) at Feb. 28, 2022 32,588 32,600                      
Beginning balance at Nov. 30, 2021     408.5   888.7   (59.9) 1,237.3   162.7 1,400.0    
Beginning balance (in shares) at Nov. 30, 2021   32,500                      
Beginning balance at Nov. 30, 2021                         29.7
Net earnings (loss) $ 11.2       12.8     12.8   (0.4) 12.4   (1.2)
Other comprehensive income (loss), net 6.6           6.6 6.6     6.6    
Noncontrolling interest adjustments                   (0.4) (0.4)    
Joint venture partner distribution declared                   (7.8) (7.8)    
Restricted stock awards (net of cancellations)     1.4         1.4     1.4    
Restricted stock awards (net of cancellations) (in shares)   100                      
Unamortized restricted stock     (1.3)         (1.3)     (1.3)    
Restricted stock amortization     4.8         4.8     4.8    
Repurchase of stock               9.0     9.0    
Cash dividends         (9.0)                
Ending balance at Feb. 28, 2022 $ 1,406.7 $ 32.6 $ 413.4   $ 892.5   $ (53.3) $ 1,252.6   $ 154.1 $ 1,406.7   $ 28.5
Ending Balance (in shares) at Feb. 28, 2022 32,588 32,600